🇺🇸 FDA
Patent

US 10765776

Tissue-derived biomaterial composition and methods for ocular and other therapeutic applications

granted A61KA61K35/30

Quick answer

US patent 10765776 (Tissue-derived biomaterial composition and methods for ocular and other therapeutic applications) held by SOUTH DAKOTA BOARD OF REGENTS (SDBOR) expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SOUTH DAKOTA BOARD OF REGENTS (SDBOR)
Grant date
Tue Sep 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K35/30